Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
November 2015 Vol 8, No 8
Perspectives
My Kind of Town
David B. Nash, MD, MBA
Read More
Practice Management
Characteristics of Academic Detailing: Results of a Literature Review
Thomas J. Van Hoof, MD, EdD
,
Lisa G. Harrison, MSN
,
Nicole E. Miller, BS
,
Maryanne S. Pappas, MS
,
Michael A. Fischer, MD, MS
Read More
Original Research
Reviewing the Unmet Needs of Patients with Multiple Sclerosis
Stanton R. Mehr
,
Marj P. Zimmerman, BSPharm, MS
Read More
Original Research
How Do PCSK9 Inhibitors Stack Up to Statins for Low-Density Lipoprotein Cholesterol Control?
Marj P. Zimmerman, BSPharm, MS
Read More
Original Research
The Latest Innovations in the Drug Pipeline for Multiple Sclerosis
Lea Radick
,
Stanton R. Mehr
Read More
Results 1 - 5 of 5